Hydrogen-generating Si-based agent protects against skin flap ischemia-reperfusion injury in rats.
In rats, the Si-based agent was found to effectively suppress I/R injury in skin flaps, and allow for the production of a large amount of hydrogen continuously via oral administration with a low likelihood of adverse events. These preclinical findings add evidence…
Read Article